|
1
|
Shaukat U, Ismail M and Mehmood N:
Epidemiology, major risk factors and genetic predisposition for
breast cancer in the Pakistani population. Asian Pac J Cancer Prev.
14:5625–5629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ortiz-Martínez F, Sanmartín E,
Pomares-Navarro E, Pérez-Balaguer A, Andrés L, Sánchez-Payá J,
Aranda FI, Lerma E and Peiró G: Osteopontin regulates VEGFA and
ICAM-1 mRNA expression in breast carcinoma. Am J Clin Pathol.
143:812–822. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan L, Strasser-Weipp K, Li J-J, St Louis
J, Finkelstein DM, Yu K-D, Chen W-Q, Shao Z-M and Goss PE: Breast
cancer in China. Lancet Oncol. 15:pp. e279–e289. 2014, http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970567-9/abstract.
View Article : Google Scholar
|
|
4
|
Kaulfuss S, Herr AM, Büchner A, Hemmerlein
B, Günthert AR and Burfeind P: Leupaxin is expressed in mammary
carcinoma and acts as a transcriptional activator of the estrogen
receptor α. Int J Oncol. 47:106–114. 2015.PubMed/NCBI
|
|
5
|
Müller V, Fuxius S, Steffens CC,
Lerchenmüller C, Luhn B, Vehling-Kaiser U, Hurst U, Hahn LJ,
Soeling U, Wohlfarth T, et al: Quality of life under capecitabine
(Xeloda®) in patients with metastatic breast cancer:
Data from a German non-interventional surveillance study. Oncol Res
Treat. 37:748–755. 2014. View Article : Google Scholar
|
|
6
|
Ramos TN, Bullard DC and Barnum SR:
ICAM-1: Isoforms and phenotypes. J Immunol. 192:4469–4474. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Veitonmäki N, Hansson M, Zhan F, Sundberg
A, Löfstedt T, Ljungars A, Li ZC, Martinsson-Niskanen T, Zeng M,
Yang Y, et al: A human ICAM-1 antibody isolated by a function-first
approach has potent macrophage-dependent antimyeloma activity in
vivo. Cancer Cell. 23:502–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haustein M, Ramer R, Linnebacher M, Manda
K and Hinz B: Cannabinoids increase lung cancer cell lysis by
lymphokine-activated killer cells via upregulation of ICAM-1.
Biochem Pharmacol. 92:312–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kotteas EA, Boulas P, Gkiozos I, Tsagkouli
S, Tsoukalas G and Syrigos KN: The intercellular cell adhesion
molecule-1 (ICAM-1) in lung cancer: Implications for disease
progression and prognosis. Anticancer Res. 34:4665–4672.
2014.PubMed/NCBI
|
|
10
|
Martin ES: The BCSC-1 locus at chromosome
11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci
USA. 100:11517–11522. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anghel SI, Correa-Rocha R, Budinska E,
Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi
D, Ghanem GE, et al: Breast cancer suppressor candidate-1 (BCSC-1)
is a melanoma tumor suppressor that down regulates MITF. Pigment
Cell Melanoma Res. 25:482–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rossé C, Lodillinsky C, Fuhrmann L,
Nourieh M, Monteiro P, Irondelle M, Lagoutte E, Vacher S, Waharte
F, Paul-Gilloteaux P, et al: Control of MT1-MMP transport by
atypical PKC during breast-cancer progression. Proc Natl Acad Sci
USA. 111:E1872–E1879. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugiyama N, Gucciardo E, Tatti O,
Varjosalo M, Hyytiäinen M, Gstaiger M and Lehti K: EphA2 cleavage
by MT1-MMP triggers single cancer cell invasion via homotypic cell
repulsion. J Cell Biol. 201:467–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan J, Jiang Y, Ye M, Liu W and Feng L:
The clinical value of lymphatic vessel density, intercellular
adhesion molecule 1 and vascular cell adhesion molecule 1
expression in patients with oral tongue squamous cell carcinoma. J
Cancer Res Ther. 10(Suppl): C125–C130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alasehirli B, Oğuz E, Oksuzler E, Koruk I,
Oztuzcu S, Ozkara E, Karakok M, Erbagcı AB and Demiryurek AT:
Investigation of intercellular adhesion molecules (ICAMs) gene
expressions in patients with Barrett's esophagus. Tumour Biol.
35:4907–4912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu J and Jin ML: Short-hairpin
RNA-mediated MTA2 silencing inhibits human breast cancer cell line
MDA-MB231 proliferation and metastasis. Asian Pac J Cancer Prev.
15:5577–5582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu S, Han L, Wang X, Liu Z, Ding S, Lu J,
Bi D, Mei Y and Niu Z: Nephroblastoma overexpressed gene (NOV)
enhances RCC cell motility through upregulation of ICAM-1 and COX-2
expression via Akt pathway. Int J Clin Exp Pathol. 8:1302–1311.
2015.PubMed/NCBI
|
|
18
|
Guo P, Huang J, Wang L, Jia D, Yang J,
Dillon DA, Zurakowski D, Mao H, Moses MA and Auguste DT: ICAM-1 as
a molecular target for triple negative breast cancer. Proc Natl
Acad Sci USA. 111:14710–14715. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jenkinson C, Elliott V, Menon U,
Apostolidou S, Fourkala OE, Gentry-Maharaj A, Pereira SP, Jacobs I,
Cox TF, Greenhalf W, et al: Evaluation in pre-diagnosis samples
discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of
pancreatic cancer. J Proteomics. 113:400–402. 2015. View Article : Google Scholar
|
|
20
|
Liu S, Li N, Yu X, Xiao X, Cheng K, Hu J,
Wang J, Zhang D, Cheng S and Liu S: Expression of intercellular
adhesion molecule 1 by hepatocellular carcinoma stem cells and
circulating tumor cells. Gastroenterology. 144:1031–1041.e10. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi X, Jiang J, Ye X, Liu Y, Wu Q and Wang
L: Prognostic prediction and diagnostic role of intercellular
adhesion molecule-1 (ICAM1) expression in clear cell renal cell
carcinoma. J Mol Histol. 45:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong Z, Fu S, Xu X, Yang Y, Du L, Li W,
Kan S, Li Z, Zhang X, Wang L, et al: Leptin-mediated regulation of
ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell
migration. Br J Cancer. 110:1801–1810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou CH, Lin FL, Tong KB, Hou SM and Liu
JF: Transforming growth factor alpha promotes osteosarcoma
metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem
Pharmacol. 89:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Howard K, Lo KK, Ao L, Gamboni F, Edil BH,
Schulick R and Barnett CC Jr: Intercellular adhesion molecule-1
mediates murine colon adenocarcinoma invasion. J Surg Res.
187:19–23. 2014. View Article : Google Scholar
|
|
25
|
Liou GY, Döppler H, Necela B, Edenfield B,
Zhang L, Dawson DW and Storz P: Mutant KRAS-induced expression of
ICAM-1 in pancreatic acinar cells causes attraction of macrophages
to expedite the formation of precancerous lesions. Cancer Discov.
5:52–63. 2015. View Article : Google Scholar :
|
|
26
|
Strell C, Lang K, Niggemann B, Zaenker KS
and Entschladen F: Neutrophil granulocytes promote the migratory
activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Exp
Cell Res. 316:138–148. 2010. View Article : Google Scholar
|
|
27
|
Viola K, Kopf S, Huttary N, Vonach C,
Kretschy N, Teichmann M, Giessrigl B, Raab I, Stary S, Krieger S,
et al: Bay11-7082 inhibits the disintegration of the
lymph-endothelial barrier triggered by MCF-7 breast cancer
spheroids; the role of ICAM-1 and adhesion. Br J Cancer.
108:564–569. 2013. View Article : Google Scholar :
|
|
28
|
Ogawa Y, Hirakawa K, Nakata B, Fujihara T,
Sawada T, Kato Y, Yoshikawa K and Sowa M: Expression of
intercellular adhesion molecule-1 in invasive breast cancer
reflects low growth potential, negative lymph node involvement, and
good prognosis. Clin Cancer Res. 4:31–36. 1998.PubMed/NCBI
|
|
29
|
Budinsky AC, Brodowicz T, Wiltschke C,
Czerwenka K, Michl I, Krainer M and Zielinski CC: Decreased
expression of ICAM-1 and its induction by tumor necrosis factor on
breast-cancer cells in vitro. Int J Cancer. 71:1086–1090. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ren Z, Kang W, Wang L, Sun B, Ma J, Zheng
C, Sun J, Tian Z, Yang X and Xiao W: E2F1 renders prostate cancer
cell resistant to ICAM-1 mediated antitumor immunity by NF-κB
modulation. Mol Cancer. 13:842014. View Article : Google Scholar
|
|
31
|
Ramer R, Bublitz K, Freimuth N, Merkord J,
Rohde H, Haustein M, Borchert P, Schmuhl E, Linnebacher M and Hinz
B: Cannabidiol inhibits lung cancer cell invasion and metastasis
via intercellular adhesion molecule-1. FASEB J. 26:1535–1548. 2012.
View Article : Google Scholar
|
|
32
|
de Groote ML, Kazemier HG, Huisman C, van
der Gun BTF, Faas MM and Rots MG: Upregulation of endogenous ICAM-1
reduces ovarian cancer cell growth in the absence of immune cells.
Int J Cancer. 134:280–290. 2014. View Article : Google Scholar
|
|
33
|
Lu H, Hu L, Yu L, Wang X, Urvalek AM, Li
T, Shen C, Mukherjee D, Lahiri SK, Wason MS, et al: KLF8 and FAK co
operatively enrich the active MMP14 on the cell surface required
for the metastatic progression of breast cancer. Oncogene.
33:2909–2917. 2014. View Article : Google Scholar :
|
|
34
|
Essick E, Sithu S, Dean W and D'Souza S:
Pervanadate–induced shedding of the intercellular adhesion molecule
(ICAM)-1 ectodomain is mediated by membrane type-1 matrix
metallopro-teinase (MT1-MMP). Mol Cell Biochem. 314:151–159. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park JK, Park SH, So K, Bae IH, Yoo YD and
Um HD: ICAM-3 enhances the migratory and invasive potential of
human non-small cell lung cancer cells by inducing MMP-2 and MMP-9
via Akt and CREB. Int J Oncol. 36:181–192. 2010.
|
